IgG from 'seronegative' myasthenia gravis patients binds to a muscle cell line, TE671, but not to human acetylcholine receptor

Annals of Neurology

Volumn 47, Issue 4, 2000, Pages 504-510

  Blaes, Franz ^a   Beeson, David ^a   Plested, Paul ^a   Lang, Bethan ^a   Vincent, Angela ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINERGIC RECEPTOR; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY;

ADOLESCENT; ADULT; ANTIBODY TITER; ANTIGEN ANTIBODY REACTION; ANTIGEN BINDING; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTER; HUMAN; HUMAN CELL; KIDNEY CELL; MALE; MYASTHENIA GRAVIS; NEUROMUSCULAR JUNCTION DISORDER; PRIORITY JOURNAL;

ADULT; ANTIBODY SPECIFICITY; AUTOANTIBODIES; FETUS; FLOW CYTOMETRY; HUMANS; IMMUNOGLOBULIN G; KIDNEY; MUSCLE NEOPLASMS; MYASTHENIA GRAVIS; RECEPTORS, CHOLINERGIC; RHABDOMYOSARCOMA, EMBRYONAL; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0034032954     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8249(200004)47:4<504::AID-ANA14>3.0.CO;2-Q     Document Type: Article

References (23)

1. Drachman DB. Myasthenia gravis. N Engl J Med 1994;330: 1797-1810
2. Solliven BC, Lange DJ, Penn AS, et al. Seronegative myasthenia gravis. Neurology 1988;38:514-517
3. Vincent A, Li Z, Hart A, et al. Seronegative myasthenia gravis: evidence for plasma factor(s) interfering with acetylcholine recepior function. Ann NY Acad Sci 1993;681:529-538
4. Mossman S, Vincent A, Newsom-Davis J. Myasthenia gravis without acetylcholine receptor antibody: a distinct disease entity. Lancet 1986;1:116-119
5. Burges J, Vincent A, Molenaar PC, et al. Passive transfer of seronegative myasthenia gravis to mice. Muscle Nerve 1994;17: 1393-1400
6. Evoli A, Batocchi AP, Lo Monaco M, et al. Clinical heterogeneity of seronegative myasthenia gravis. Neuromuscul Disord 1996;6:155-161
7. Yamamoto T, Vincent A, Ciulla TA, et al. Seronegative myasthenia gravis: a plasma factor inhibiting agonist-induced acetylcholine receptor function copurifies with IgM. Ann Neurol 1991;30:550-557
8. Barrett-Jolley R, Byrne N, Vincent A, Newsom-Davis J. Plasma from patients with seronegative myasthenia gravis inhibit nAChR responses in the TE671/RD cell line. Pflügers Arch 1994;428:492-498
9. Plested CP, Newsom-Davis J, Vincent A. Seronegative myasthenia plasmas and non-IgG fractions transiently inhibit nAChR function. Ann NY Acad Sci 1998;841:501-504
10. Brooke EB, Pachner AR, Drachman DB, Kantor FS. A sensitive rosetting assay for detection of acetylcholine receptor antibodies using BC3H1 cells: positive results in myasthenia gravis. J Neuroimmunol 1990;28:83-93
11. Li Z, Forester N, Vincent A. Modulation of acetylcholine receptor function in TE671 cells by non-AChR ligands: possible relevance to seronegative myasthenia gravis. J Neuroimmunol 1996;64:179-183
12. Vincent A, Newsom-Davis J. Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: results in 153 validated cases and 1967 diagnostic assays. J Neurol Neurosurg Psychiatry 1985;48:1246-1252
13. Beeson D, Omar M, Bermudez I, et al. Stable expression of the adult subtype of human muscle acetylcholine receptor in the TE671 cell line. Neurosci Lett 1996;207:57-60
14. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989
15. Jacobson L, Beeson D, Tzartos S, Vincent A. Monoclonal antibodies raised against human acetylcholine receptor bind to all five subunits of the fetal isoform. J Neuroimmunol 98: 112-120
16. Vincent A, Jacobson L, Plested P, et al. Antibodies affecting ion channel function in acquited neuromyotonia, in seropositive and seronegative myasthenia gravis, and in antibody-mediated arthrogryposis multiplex congenita. Ann NY Acad Sci 1998; 841:482-496
17. Lu CZ, Lu L, Hao ZS, et al. Antibody-secreting cells to acetylcholine receptor and to presynaptic membrane receptor in seronegative myasthenia gravis. J Neuroimmunol 1993;43:145-150
18. Vincent A, Plested P, Tang T, Newsom-Davis J. Serum factors from seronegative myasthenia gravis patients and acetylcholine receptor phosphorylation. Ann Neurol 1998;44:439 (Abstract)
19. Yoshikawa H, Lennon VA. Acetylcholine receptor antibody secretion by thymocytes: relationship to myasthenia gravis. Neurology 1997;49:562-567
20. Karni A, Zisman E, Katz-Levy Y, et al. Reactivity of T cells from seronegative patients with myasthenia gravis to T cell epitopes of the human acetylcholine receptor. Neurology 1997; 48:1638-1642
21. Willcox N, Schluep M, Ritter MA, Newsom-Davis J. The thymus in seronegative myasthenia gravis patients. J Neurol 1991; 238:256-261
22. Verna PK, Oger JJ. Seronegative generalized myasthenia gravis: low frequency of thymic pathology. Neurology 1992;42:586-589
23. Sharshar T, Lacroix-Desmazes, Mouthon L, et al. Selective impairment of serum antibody repertoires towards muscle and thymus antigens in patients with seronegative and seropositive myasthenia gravis. Eur J Immunol 1998;28:2344-2354